发明名称 |
AVOIDING NARCOLEPSY RISK IN INFLUENZA VACCINES |
摘要 |
The invention provides influenza vaccines and methods which improve the safety of influenza vaccines further, in particular in relation to the risk of causing narcolepsy in adjuvanted vaccines. |
申请公布号 |
US2014335116(A1) |
申请公布日期 |
2014.11.13 |
申请号 |
US201414275373 |
申请日期 |
2014.05.12 |
申请人 |
NOVARTIS AG |
发明人 |
Ahmed Syed Sohail;Steinman Lawrence;Volkmuth Wayne |
分类号 |
C07K14/005;C12N7/00;G01N33/569 |
主分类号 |
C07K14/005 |
代理机构 |
|
代理人 |
|
主权项 |
1. An influenza vaccine composition comprising influenza virus A nucleoprotein wherein a fragment of said nucleoprotein equivalent to amino acids 106 to 126 of SEQ ID NO: 2 binds to an MHC class II receptor comprising HLA DQB1*0602 with a lower affinity than a peptide having the amino acid sequence shown in SEQ ID NO:1, with the proviso that if all influenza A nucleoprotein in the composition comprises the amino acid sequence shown in SEQ ID NO: 12, then the vaccine composition is not based on strain A/California/7/2009 (H1N1)-derived strain NYMC X-181. |
地址 |
Basel CH |